Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger BED domain-containing protein 5 (ZBED5) is a human protein encoded by the ZBED5 gene, notable for its origin from a domesticated DNA transposon, specifically a Charlie-like element[1][3][6]. ZBED genes, including ZBED5, are part of a regulatory protein family in vertebrates, unified by a BED-type zinc finger domain that binds DNA elements, consistent with their presumed functions as transcription factors or gene regulators[2][5][6][7]. ZBED5 does not appear to be an active transposase, as it lacks terminal inverted repeats, but is conserved among mammals of the Laurasiatheria branch[1]. Although detailed, unique biological functions for ZBED5 remain under-characterized, ZBED family proteins overall are important for DNA-binding and regulatory activities[2][3][6]. To date, there are no established roles for ZBED5 as a common therapeutic target, biomarker, or as directly involved in human disease; it also lacks known interacting drugs or associated safety concerns[3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger BED domain-containing protein 5 (ZBED5).